With nearly 800 cases adjudicated or pending thus far at the Unified Patent Court (UPC), a possible procedural gap has ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

Companies and inventors from around the world filed 199,264 patent applications at the European Patent Office (EPO) last year ...

European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 ...

The European Patent Office’s latest report shows patent filings holding steady, with computer technology leading growth.

Lawmakers of the European Parliament’s Legal Affairs committee have demanded clarity from the European Commission on its ...

MUNICH, March 31, 2025 /PRNewswire/ -- The European Patent Office (EPO) published its annual Patent Index 2024 today, revealing that a total of 199,264 European patent applications were filed last ...

CureVac (CVAC) announced that the European Patent Office has confirmed the validity of the company’s European patent EP 3 708 668 B1 subject to ...

Shares of CureVac climbed after the European Patent Office confirmed the validity of a patent that has been the subject of a lawsuit filed by BioNTech. The stock rose 7% to $2.99 on Friday. Shares ...

European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 B1 and maintains the patent in amended form Confirming validity of ...